Revolution Medicines logo

Vice President, Global Scientific Communications, Medical Information, Content and Education

Revolution Medicines

Redwood City, CARemotePosted 1 day ago$294,000 - $367,000
Full TimeDirector & AboveMedical AffairsBiotechnology
Original posting ↗

Summary

The Vice President, Global Scientific Communications, Medical Information, Content and Education will lead scientific narrative, publication strategy, medical content and training, and medical education across Revolution Medicines' portfolio. This leader will translate complex and evolving evidence into accurate, clear and clinically relevant scientific communications and medical information services, establishing an integrated approach across Global, Regional and Country Medical Affairs.

Job description

The Opportunity

The Vice President, Global Scientific Communications, Medical Information, Content and Education will lead scientific narrative, publication strategy, medical content and training, and medical education across Revolution Medicines' portfolio. This leader will translate complex and evolving evidence into accurate, clear and clinically relevant scientific communications and medical information services, establishing an integrated approach across Global, Regional and Country Medical Affairs.

Global Medical Information Leadership

  • Own the global strategy, operating model and delivery of Medical Information services across the portfolio.
  • Build and scale Global Medical Information to support geographic expansion, multiple launches and increasing inquiry volume and complexity.
  • Oversee timely, accurate, balanced and evidence-based responses to unsolicited inquiries from healthcare professionals, patients, caregivers and other stakeholders.
  • Lead the development and maintenance of standard scientific response documents, frequently asked questions and supporting reference resources.
  • Establish scientific and service standards for inquiry intake, triage, response, escalation, documentation and quality assurance.
  • Define global standards and regional and country responsibilities, enabling local adaptation to language, healthcare context and applicable requirements.
  • Oversee medical information service providers and contact centers, including scientific training, service quality, capacity and performance.
  • Ensure appropriate processes for identifying and routing adverse events, product complaints and other reportable information to accountable functions.
  • Establish medical information readiness for launches, new indications, major data releases and emerging scientific questions.
  • Partner with Pharmacovigilance, Quality, Regulatory Affairs, Legal and Compliance on processes supporting safe and appropriate information exchange.

Scientific Narrative and Communication Strategy

  • Lead the development and evolution of portfolio and asset-level scientific narratives in partnership with therapeutic area leaders and evidence-generating functions.
  • Ensure narratives reflect the totality of evidence, unmet medical needs, study limitations and the evolving treatment landscape.
  • Translate medical strategy and evidence priorities into integrated scientific communication plans.
  • Establish consistent scientific interpretation across publications, medical content and educational materials.
  • Advise Global Medical Affairs leadership on communication priorities, emerging evidence and scientific issues requiring clarification.
  • Coordinate scientific communication around major data releases and regulatory milestones with the relevant functional owners.

Publication Strategy and Delivery

  • Lead global publication strategy and planning in partnership with Clinical Development, Global and Regional Medical Affairs, HEOR, Biostatistics, Research, Translational Science and other evidence-generating functions.
  • Oversee the development and delivery of manuscripts, abstracts, posters and scientific presentations.
  • Establish publication-specific processes for prioritization, data readiness, authorship, scientific review and approval.
  • Confirm that proposed publications are supported by appropriately reviewed data and that unresolved scientific questions are addressed before progression.
  • Ensure publications provide balanced interpretation and appropriate context across the body of evidence.
  • Manage external author collaboration and publication agency partnerships, preserving scientific independence and transparency.
  • Coordinate publication timelines with medical communication and education plans.

Scientific Content Development and Stewardship

  • Own the strategy, development and maintenance of core global scientific content across assets, indications and disease areas.
  • Oversee scientific platforms, data presentations, disease-state resources, scientific narratives and supporting medical education materials.
  • Establish standards for scientific accuracy, evidence traceability, clinical relevance and appropriate presentation of uncertainty.
  • Define scientific requirements for content review, updates, version control and retirement.
  • Develop modular content that Regional and Country teams can adapt within agreed scientific parameters.
  • Integrate Medical Information response resources with the broader scientific content strategy, ensuring consistent evidence interpretation while tailoring materials to the purpose and audience of an inquiry.
  • Maintain alignment with Field Medical on the scientific content needed for effective external exchange.

Scientific and Medical Education

  • Own medical education strategy, learning objectives, curricula and scientific content informed by identified stakeholder needs.
  • Lead the scientific design of company-led educational programs, including selection of topics, formats and faculty expertise.
  • Define scientific priorities and needs assessments for independent medical education support, working through the accountable grants function and applicable independent review processes.
  • Lead internal scientific curricula and training content in partnership with therapeutic area experts.
  • Ensure education addresses disease biology, evidence interpretation, treatment considerations and emerging scientific developments.
  • Establish scientific and learning criteria for evaluating educational quality and effectiveness.

Congress Scientific Content

  • Lead scientific communication objectives and content priorities for medical congresses.
  • Oversee congress-related publications, scientific presentations, educational content and internal scientific briefings.
  • Coordinate content readiness with publication timelines, data availability and review requirements.
  • Develop scientific preparation materials, including evidence interpretation and anticipated scientific questions.
  • Partner with Congress Planning and Execution on delivery requirements, milestones and dependencies.
  • Use congress insights supplied by the insights function to refine subsequent scientific content and education.

Scientific Support for Medical Launches

  • Define and deliver the scientific narrative, content and education required for medical launches.
  • Establish content readiness milestones within the integrated medical launch plan.
  • Ensure materials accurately communicate the available evidence and address anticipated scientific information needs.
  • Ensure Medical Information launch readiness, including response resources, trained service teams, inquiry escalation pathways and capacity to address anticipated demand.
  • Partner with Field Medical, Regional and Country teams on scientific preparation.
  • Work with Medical Launch Excellence to identify content dependencies and resolve readiness gaps.
  • Update scientific content and education as evidence and stakeholder needs evolve after launch.

Global–Regional–Country Scientific Coordination

  • Engage Regional and Country Medical Affairs early in scientific content and education planning.
  • Establish core global scientific content and clear parameters for local adaptation.
  • Resolve scientific interpretation questions with relevant subject matter experts and accountable medical leaders.
  • Incorporate regional and country needs into publication, content and education priorities.
  • Partner with the Executive Director, Global Medical Affairs Alignment and Integration on cross-geographic dependencies and issues requiring broader alignment.

Coordination with Engagement, Analytics & Impact

  • Use stakeholder needs assessments and synthesized insights from the analytics and engagement functions to inform scientific priorities.
  • Define scientific content and learning requirements for digital delivery; partner with the complementary VP on platforms, channels and implementation.
  • Provide scientific requirements, expert review and acceptance criteria for AI applications affecting content or education.
  • Define the scientific questions and learning outcomes to be assessed; partner with Global Medical Analytics and Insights on measurement design, data collection and analysis.
  • Apply findings from engagement and education assessments to improve content quality and relevance.
  • Establish joint planning with the complementary VP for initiatives requiring both scientific deliverables and enabling capabilities.

People, Resources and Scientific Governance

  • Retain, build and develop a team with expertise in scientific communications, publications, medical education, medical content and training.
  • Lead and develop Global Medical Information personnel and oversee service-provider budgets, scientific quality and operational performance.
  • Manage functional budgets, capacity and scientific agency partnerships.
  • Establish clear accountability for scientific quality and timely delivery.
  • Ensure activities follow applicable requirements, company policies and standards for scientific integrity and nonpromotional communication.
  • Partner with Global Medical Affairs Effectiveness & Operations on integrated planning, resource processes and operational dependencies.
  • Foster a culture of rigorous evidence interpretation, collaboration and continuous improvement.

Requirements

  • Advanced scientific or clinical degree required; MD, PharmD or PhD preferred
  • >20 years of substantial progressive experience in biotechnology or pharmaceutical Medical Affairs, including senior leadership of scientific communications, publications or medical education
  • Experience leading or overseeing Medical Information services, including scientific response development, global service delivery, vendor management and quality governance
  • Demonstrated success developing scientific narratives and integrated communication strategies across multiple assets or indications
  • Strong expertise in clinical evidence interpretation, publication practices and scientific content governance
  • Experience supporting development-stage and marketed products, major data releases and launches
  • Experience collaborating across Global, Regional and Country Medical Affairs
  • Proven ability to build teams, lead through a matrix and manage scientific agency partnerships
  • Ability to collaborate effectively with analytics, engagement and technology leaders
  • Oncology experience required
  • Scientific credibility and sound judgment
  • Ability to communicate complex evidence clearly while preserving nuance
  • Strategic prioritization and disciplined delivery
  • Strong collaboration and influence across functional boundaries
  • Commitment to scientific integrity and patient-centered communication
  • Ability to develop talent and scale scientific capabilities

Benefits

  • Competitive cash compensation
  • Equity awards
  • Benefits
  • Learning and development opportunities

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.